🔓 Unlock the full profile of Ravi Venkataramanan (Navin Fluorine International Ltd.), including verified contact details, financial insights, and professional associations.
See Ravi Venkataramanan Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: rav*****@nav******.com
Mobile: 73700*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Ravi Venkataramanan co-founded Samnan Chemicals Pvt Ltd, starting in October 2023, marking a significant new venture in the chemical industry.
- Prior to this, Ravi served as the Chief Executive Officer of Navin Fluorine International Ltd. from February 2022 until October 2023, leading strategic initiatives that expanded the company’s market presence.
- During the tenure at Navin Fluorine International Ltd., Ravi played a pivotal role in enhancing operational efficiencies and driving innovative chemical solutions tailored to diverse industrial needs.
- Ravi's leadership at Aurigene Pharmaceutical Services Limited as CEO from June 2020 to February 2022 was marked by improvements in service offerings and client engagement in the pharmaceutical sector.
- In a previous role as the Global Business Head of Custom Pharmaceutical Services at Dr. Reddy’s Laboratories from December 2018 to June 2020, Ravi was instrumental in expanding the global reach of personalized pharmaceutical services.
- Ravi held multiple senior positions at Sai Life Sciences Ltd, including Senior Vice President of Global Business Development & Program Management from April 2018 to December 2018 and Vice President & Head of Products - API & Formulations from October 2013 to December 2018, focusing on strategic product development and market penetration.
- In these roles, Ravi faced numerous challenges, including navigating competitive market landscapes and evolving regulatory frameworks while ensuring robust growth and profitability for the organizations.
- Ravi's extensive experience across various leadership positions reflects a strong commitment to advancing innovation within the chemical and pharmaceutical industries.